Gozen Bioworks Corp.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Gozen Bioworks Corp. - overview

Established

2022

Location

San Francisco, CA, US

Primary Industry

Materials

About

Based in California, US, and founded in 2022 by Chief Executive Officer Ece Gozen, Chief Operating Officer Pelin Gozen, and Chief Strategy Officer Onur Eren Gozen, Bioworks Corp. operates as a developer of biomaterials for use in a variety of industries, including fashion, automotive, and home furnishings. In October 2023, Gozen Bioworks Corp. raised USD 3.


3 million in seed funding led by Happiness Capital, with participation from ACCELR8, Astor Investment Management, and SOSV. Gozen Bioworks Corp. creates a biomaterial known as lunaform, which is an alternative to traditional materials and developed from microorganisms to craft ultra-crystalline patterns. The company’s biomaterial is vegan and plastic-free, with a premium feel and natural translucency.


In addition, the firm produces in a 7-day process to reduce costs and integrate into supply chains. Gozen Bioworks Corp. serves a wide range of industries, such as fashion, automotive, accessories, and aircraft.


Current Investors

Astor Investment Management, SOSV, Happiness Capital

Primary Industry

Materials

Sub Industries

Biomaterials

Website

www.gozen.world

Verticals

Manufacturing

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.